Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia-A Systematic Review

被引:10
作者
Kosinska-Kaczynska, Katarzyna [1 ]
Zgliczynska, Magdalena [1 ,2 ]
Kozlowski, Szymon [3 ]
Wicherek, Lukasz [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Obstet & Gynecol 2, PL-01809 Warsaw, Poland
[2] Med Univ Warsaw, Lab Ctr Preclin Res, Chair & Dept Expt & Clin Physiol, PL-02106 Warsaw, Poland
[3] Med Univ Warsaw, Univ Ctr Woman & Newborn Hlth, PL-02015 Warsaw, Poland
关键词
placental growth factor; serum soluble fms-like tyrosine kinase-1; endoglin; preeclampsia; prediction; twin pregnancy; SFLT-1/PLGF RATIO; HYPERTENSIVE DISORDERS; ANGIOGENIC FACTORS; PREDICTIVE-VALUE; PREGNANCIES; SINGLETON; OUTCOMES; WOMEN; 1ST; COMPLICATIONS;
D O I
10.3390/jcm9010183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple gestation is one of the key risk factors for the occurrence of preeclampsia (PE). Soluble fms-like tyrosine kinase-1, placental growth factor, and soluble endoglin are molecules involved in the process of angiogenesis with a proven role in the pathogenesis of PE. The aim of the review was to summarize available data on maternal serum levels of the above-mentioned factors and their usefulness in predicting PE in twin pregnancies. Only original research articles written in English were considered eligible. Reviews, chapters, case studies, conference papers, experts' opinions, editorials, and letters were excluded from the analysis. No publication date limitations were imposed. The systematic literature search using PubMed/MEDLINE, Scopus, Embase, and Cochrane Library databases identified 338 articles, 10 of which were included in the final qualitative analyses. The included studies showed significant differences in maternal serum levels of the discussed factors between women with twin pregnancies with PE and those who did not develop PE, and their promising performance in predicting PE, alone or in combination with other factors. The identification of the most effective algorithms, their prompt introduction to the clinical practice, and further assessment of the real-life performance should become a priority.
引用
收藏
页数:13
相关论文
共 50 条
[31]   Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage [J].
Jayasena, C. N. ;
Abbara, A. ;
Comninos, A. N. ;
Narayanaswamy, S. ;
Maffe, J. Gonzalez ;
Izzi-Engbeaya, C. ;
Oldham, J. ;
Lee, T. T. M. ;
Sarang, Z. ;
Malik, Z. ;
Dhanjal, M. K. ;
Williamson, C. ;
Regan, L. ;
Bloom, S. R. ;
Dhillo, W. S. .
HUMAN REPRODUCTION, 2016, 31 (12) :2681-2688
[32]   Characterization of the Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Complicated by Fetal Growth Restriction [J].
Herraiz, Ignacio ;
Droege, Lisa Antonia ;
Gomez-Montes, Enery ;
Henrich, Wolfgang ;
Galindo, Alberto ;
Verlohren, Stefan .
OBSTETRICS AND GYNECOLOGY, 2014, 124 (02) :265-273
[33]   Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia [J].
Radulescu, Carmen ;
Bacarea, Anca ;
Hutanu, Adina ;
Gabor, Rozalia ;
Dobreanu, Minodora .
MEDIATORS OF INFLAMMATION, 2016, 2016
[34]   The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application [J].
Lapaire, Olav ;
Shennan, Andrew ;
Stepan, Holger .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 151 (02) :122-129
[35]   Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida [J].
Phupong, Vorapong ;
Areeruk, Wilasinee ;
Tantbirojn, Patau ;
Lertkhachonsuk, Ruangsak .
HYPERTENSION IN PREGNANCY, 2020, 39 (02) :139-144
[36]   Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies [J].
Powers, Robert W. ;
Jeyabalan, Arun ;
Clifton, Rebecca G. ;
Van Dorsten, Peter ;
Hauth, John C. ;
Klebanoff, Mark A. ;
Lindheimer, Marshall D. ;
Sibai, Baha ;
Landon, Mark ;
Miodovnik, Menachem .
PLOS ONE, 2010, 5 (10)
[37]   Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester [J].
Chelli, Dalenda ;
Hamdi, Asma ;
Saoudi, Sarah ;
Jenayah, Amel A. ;
Zagre, Armand ;
Jguerim, Haithem ;
Bedis, Channoufi ;
Sfar, Ezzeddine .
CLINICAL LABORATORY, 2016, 62 (10) :1927-1932
[38]   Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia [J].
Li, Jingyu ;
Cai, Ailu ;
Yuan, Qian ;
Ding, Hao ;
Zhao, Dan .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 145 (02) :176-181
[39]   Usefulness of the sFlt-1/PlGF (Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia [J].
Leanos-Miranda, Alfredo ;
Graciela Nolasco-Leanos, Ana ;
Ismael Carrillo-Juarez, Reyes ;
Jose Molina-Perez, Carlos ;
Janet Sillas-Pardo, Liliana ;
Manuel Jimenez-Trejo, Luis ;
Isordia-Salas, Irma ;
Leticia Ramirez-Valenzuela, Karla .
HYPERTENSION, 2020, 76 (03) :892-900
[40]   Maternal Periodontal Disease and Soluble Fms-Like Tyrosine Kinase-1 Expression [J].
Horton, Amanda L. ;
Boggess, Kim A. ;
Moss, Kevin L. ;
Beck, James ;
Offenbacher, Steven .
JOURNAL OF PERIODONTOLOGY, 2009, 80 (09) :1506-1510